During the past decade, Yashoda Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Yashoda Hospital" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Pfizer" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "Biocad" with 1 trials sponsored and "GREAT Network Italy" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yashoda Hospital" #1 collaborator was "Indian Society of Critical Care Medicine" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Yashoda Hospital" are "Acute Kidney Injury" (1 trials), "Advanced Non-Small Cell Lung Cancer" (1 trials), "Allergic Bronchopulmonary Aspergillosis" (1 trials), "Breast Cancer" (1 trials) and "Early Breast Cancer" (1 trials). Many other conditions were trialed in "Yashoda Hospital" in a lesser frequency.

Most popular intervention types in "Yashoda Hospital" are "Drug" (8 trials), "Combination Product" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (2 trials), "Rituximab" (2 trials), "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (1 trials), "Atezolizumab Placebo" (1 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yashoda Hospital" are 10 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Yashoda Hospital". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Yashoda Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Yashoda Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".